Literature DB >> 28138940

One-stop-shop radioiodine dosimetry in patients with Graves' disease.

Luca Giovanella1, Frederik Verburg2, Luca Ceriani3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28138940     DOI： 10.1007/s12020-017-1229-1

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  3 in total

1.  EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases.

Authors:  Heribert Hänscheid; Cristina Canzi; Wolfgang Eschner; Glenn Flux; Markus Luster; Lidia Strigari; Michael Lassmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-11       Impact factor: 9.236

2.  Pretherapeutic dosimetry before 131I therapy of benign thyroid disease. A clinical practice assessment of dosimetric parameters.

Authors:  Thomas Krohn; F F Behrendt; A Heinzel; B Müller; F M Mottaghy; F A Verburg
Journal:  Nuklearmedizin       Date:  2014-12-09       Impact factor: 1.379

3.  Calculation of therapeutic activity of radioiodine in Graves' disease by means of Marinelli's formula, using technetium (99mTc) scintigraphy.

Authors:  Piotr Szumowski; Małgorzata Mojsak; Saeid Abdelrazek; Monika Sykała; Anna Amelian-Fiłonowicz; Dorota Jurgilewicz; Janusz Myśliwiec
Journal:  Endocrine       Date:  2016-08-24       Impact factor: 3.633
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.